Spironolactone is a prescription medication that blocks the hormone aldosterone, originally developed in the late 1950s to treat fluid retention and high blood pressure. Over the decades, though, its anti-androgen properties turned it into one of the most versatile drugs in medicine, now widely prescribed for conditions ranging from heart failure and liver disease to hormonal acne, hair loss, and hirsutism in women. That range of uses, spanning cardiology, dermatology, endocrinology, and beyond, makes it unusual among medications and worth understanding in some detail.
How Spironolactone Works
Spironolactone sits on and blocks the receptor for aldosterone, a hormone your adrenal glands produce to tell your kidneys to hold on to sodium and water while shedding potassium. By blocking that signal, spironolactone helps your body release excess sodium and fluid while holding on to potassium, which is why it is classified as a “potassium-sparing diuretic.” This mechanism makes it directly useful for conditions involving fluid overload, like heart failure and cirrhosis.
But spironolactone also binds to androgen receptors, blocking the effects of testosterone and related hormones at the tissue level. It can also interfere with the production of androgens in the ovaries and adrenal glands. This second property, essentially unrelated to its diuretic action, is what opened the door to its use in skin, hair, and hormonal conditions in women. It is this dual nature that gives spironolactone its remarkably broad list of indications.
Heart Failure
One of the most important uses of spironolactone is in heart failure with reduced ejection fraction, a condition where the heart pumps blood less effectively than it should. In heart failure, aldosterone levels tend to rise, driving harmful fluid retention and contributing to scarring in heart tissue. Blocking aldosterone with spironolactone helps reduce that damage. A landmark trial in the late 1990s showed a dramatic reduction in death among patients with severe heart failure, and since then the drug has been a mainstay of treatment guidelines.
Research in older patients has reinforced these findings. A large observational study of older adults with heart failure and reduced ejection fraction found that spironolactone was associated with a lower risk of heart failure readmission and the combined outcome of readmission or death, with hazard ratios in the range of 0.87 to 0.92 depending on the analysis.1PubMed Central. Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction These benefits come with a caveat, though: the risk of dangerously high potassium levels, which we will get to in the side-effects section.
Resistant Hypertension
Some people with high blood pressure cannot get it under control even with three or more medications. This is called resistant hypertension, and spironolactone has become one of the most reliable add-on treatments for it. A study of patients already taking multiple blood pressure drugs found that adding low-dose spironolactone produced an additional average drop of roughly 25/12 mmHg at six months. That reduction was similar regardless of whether the patient had an identifiable aldosterone problem or not, and the benefit stacked on top of whatever their other medications were already doing.2PubMed. Efficacy of low-dose spironolactone in subjects with resistant hypertension
This makes spironolactone especially valuable when other treatments have been maxed out. Doctors sometimes discover along the way that a patient’s resistant hypertension was driven by excess aldosterone all along, a condition called primary aldosteronism that is more common than previously thought. But even when aldosterone levels look normal, the drug still works well for stubborn blood pressure.
Cirrhosis and Fluid Buildup
When the liver is severely scarred by cirrhosis, blood flow through it gets backed up, triggering a cascade that results in fluid collecting in the abdomen (ascites) and swelling in the legs. Aldosterone plays a major role here: the body mistakenly thinks it is running low on blood volume and ramps up aldosterone to retain more sodium and water, which only makes things worse.
Spironolactone is the first-line diuretic for managing ascites in cirrhosis. Guidelines recommend starting at 100 mg daily and increasing up to 400 mg as needed, either alone or in combination with furosemide.3Gut. Guidelines on the management of ascites in cirrhosis Because the underlying problem is excessive aldosterone activity, directly blocking that receptor works better as initial therapy than simply trying to force the kidneys to dump sodium with loop diuretics alone.
Hormonal Acne in Women
This is where spironolactone’s story gets interesting for a completely different group of patients. Androgens stimulate oil production in skin, and many women with persistent acne, particularly along the jawline and lower face, have acne that is driven or worsened by androgen activity. Because spironolactone blocks androgen receptors, it can reduce oil production and improve acne from the hormonal side rather than just fighting bacteria or unclogging pores.
A retrospective study of 110 women treated with spironolactone found that the vast majority saw improvement, with average acne scores dropping by about 73 to 78 percent across the face, chest, and back. Over half of the patients cleared completely.4PubMed Central. Spironolactone for the treatment of acne in women, a retrospective study of 110 patients A head-to-head randomized trial comparing spironolactone to the antibiotic doxycycline in women with moderate acne found that spironolactone was significantly more effective by six months, with nearly three times the treatment success rate at that point, along with better quality-of-life scores.5PubMed Central. Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females
The evidence quality is a known limitation, though. A systematic review that pulled together all available randomized trials found that most were small and at high risk of bias, with only one trial clearly showing statistical superiority over placebo at a 200 mg daily dose. At that dose, menstrual side effects were common, though they could be reduced by taking a combined oral contraceptive alongside the spironolactone.6PubMed Central. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review In practice, many dermatologists prescribe 50 to 100 mg daily to balance effectiveness against side effects, and the drug has built a strong clinical reputation despite the evidence base being somewhat thinner than you might expect for something so widely used.
Female Pattern Hair Loss
The same anti-androgen mechanism that helps with acne also makes spironolactone a treatment option for women experiencing androgenetic alopecia, the gradual thinning of hair across the top of the scalp. Androgens shrink hair follicles over time, and blocking them can slow or partially reverse that process.
A systematic review and meta-analysis of studies covering 192 patients found that roughly 57 percent of women showed improved hair loss with oral spironolactone. Results were better when the drug was combined with other therapies like minoxidil, with about 66 percent improving compared to 43 percent with spironolactone alone.7PubMed Central. The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis A randomized, double-blind, placebo-controlled pilot study in premenopausal women confirmed that the spironolactone group had greater increases in terminal hair count and hair diameter, with 38 percent achieving moderate-to-marked improvement compared to 9 percent in the placebo group.8PubMed Central. Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women
Topical formulations of spironolactone are also being explored for hair loss. A systematic review found that topical use showed efficacy for alopecia recovery with significantly fewer side effects than oral dosing, and the topical route is suitable for any gender, sidestepping the hormonal concerns that limit oral use in men.9PubMed Central. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
Hirsutism and Polycystic Ovary Syndrome
Hirsutism, the growth of coarse hair in a typically male pattern on women’s faces, chests, and backs, is one of the most distressing symptoms of excess androgen activity. It is especially common in women with polycystic ovary syndrome (PCOS). Spironolactone is one of the most frequently prescribed medications for this problem.
An early study that established the drug’s effectiveness in hirsutism found that 200 mg daily produced a clear beneficial effect on both the quantity and quality of facial hair in 19 out of 20 women with moderate-to-severe hirsutism. The improvement was similar in women with PCOS and those with no identifiable hormonal cause for their excess hair growth.10JAMA. Treatment of Hirsutism With Spironolactone A review of the literature specific to PCOS-related hirsutism found a positive trend toward spironolactone’s effectiveness, typically at doses of 100 to 200 mg daily.11PubMed. Spironolactone for hirsutism in polycystic ovary syndrome Menstrual irregularities are common at these doses, so the drug is often prescribed alongside an oral contraceptive to manage cycle disruption and to prevent pregnancy.12ScienceDirect. Steroid inhibitor Antiandrogens: Clinical applications
Hair reduction from spironolactone is not immediate. Androgens affect the hair growth cycle at a slow pace, and most women need several months of treatment before noticing a meaningful difference. The drug slows new hair growth and makes existing hair finer, but it does not eliminate hair that has already grown, so many women combine it with physical hair removal methods.
Gender-Affirming Hormone Therapy
Spironolactone is widely used in the United States as an anti-androgen in feminizing hormone therapy for transgender women. In this context, it is typically prescribed alongside estradiol, with the spironolactone helping to suppress the effects of testosterone while estrogen drives feminizing changes like breast development, fat redistribution, and softer skin.13PubMed Central. Hormone therapy for transgender patients
A systematic review of anti-androgens used in feminizing therapy found that some alternatives, including cyproterone acetate and GnRH agonists, may be more effective than spironolactone at lowering total testosterone levels in the blood. However, because spironolactone also blocks testosterone at the receptor level (not just lowering its blood concentration), the clinical difference in feminization outcomes remains unclear.14PubMed. A systematic review of antiandrogens and feminization in transgender women Cyproterone acetate is not available in the United States due to liver safety concerns, which makes spironolactone the most commonly used anti-androgen for this purpose in American practice.
Side Effects and Risks
Spironolactone’s side effects fall into two broad categories: those related to potassium and those related to hormones. Understanding which side effects apply to you depends heavily on why you are taking the drug and your overall health.
High Potassium
Because spironolactone tells the kidneys to hold on to potassium, the most serious risk is hyperkalemia, or potassium levels climbing too high. This matters most for people with kidney problems, diabetes, older adults, or anyone also taking ACE inhibitors, ARBs, or potassium supplements. In heart failure patients, hyperkalemia is a recognized contributor to underuse of the drug, since doctors worry about the consequences.15PubMed. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist A case series analyzing life-threatening hyperkalemia events found that the combination of ACE inhibitors and spironolactone requires particular caution and close monitoring in patients with kidney problems, diabetes, older age, or worsening heart failure.16PubMed. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone
For young, healthy women taking spironolactone for acne or hair concerns, the potassium risk is much lower. A study looking at over 1,800 potassium measurements in healthy young women on the drug found a hyperkalemia rate of just 0.72 percent, essentially identical to the baseline rate in the general population. In several of those cases, repeat testing came back normal, suggesting the initial readings may have been lab errors. This has led some experts to recommend against routine potassium monitoring in healthy young women on spironolactone, though many doctors still check it at least once after starting the medication.
Hormonal Side Effects
The same anti-androgen and hormonal properties that make spironolactone therapeutically useful can also cause unwanted effects. In men, the drug can cause breast tenderness or enlargement (gynecomastia) and sexual dysfunction, which is one reason it is rarely used for dermatological conditions in male patients.17PubMed. Spironolactone and endocrine dysfunction In women, menstrual irregularities are the most common hormonal complaint, especially at higher doses. Breast tenderness can also occur. These side effects are dose-dependent and often manageable by adjusting the dose or adding an oral contraceptive.
Other commonly reported side effects include dizziness (from lowered blood pressure), increased urination (it is a diuretic, after all), fatigue, and occasional headache. Most of these are mild and tend to settle after the first few weeks.
Pregnancy
Spironolactone is not recommended during pregnancy. Because it blocks androgens, there is a theoretical risk that it could interfere with the normal genital development of a male fetus. This concern comes primarily from animal studies, and actual human data are limited. A case report of a woman accidentally exposed to 240 mg daily of spironolactone for one week during mid-pregnancy documented a healthy male infant with normal genitalia at birth, but this single case cannot establish safety.18PubMed Central. Case report: A pregnant woman accidental treated with spironolactone in mid-gestation The standard medical advice is to use reliable contraception while taking spironolactone, and many prescribers combine it with an oral contraceptive for this reason, especially in women of childbearing age being treated for acne or hirsutism.
How Spironolactone Compares to Eplerenone
Eplerenone is a newer drug that blocks the same aldosterone receptor but is more selective, meaning it does not bind to androgen or progesterone receptors the way spironolactone does. This selectivity translates to fewer hormonal side effects like gynecomastia and menstrual irregularity, which makes eplerenone more tolerable for some patients, particularly men with heart failure.
In terms of blood pressure lowering, a meta-analysis of patients with resistant hypertension found no significant difference between the two drugs in their effects on systolic or diastolic blood pressure or serum potassium levels.19Journal of Asian Pacific Society of Cardiology. Spironolactone versus Eplerenone in Patients with Resistant Hypertension: A Systematic Review and Indirect Meta-analysis In heart failure, the picture is more nuanced. A real-world comparison found no difference between the two drugs in the combined outcome of cardiovascular death or hospitalization. However, eplerenone was associated with lower cardiovascular and all-cause mortality, and patients on eplerenone were less likely to stop the drug due to side effects.20PubMed. Real world comparison of spironolactone and eplerenone in patients with heart failure A separate study confirmed the mortality advantage for eplerenone while finding no difference in the composite heart failure outcome.21PubMed Central. The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF
Despite these findings, spironolactone remains far more commonly prescribed than eplerenone. It is substantially cheaper, has a longer track record, and is the only option when the anti-androgen effects are actually desired, as in acne, hirsutism, or gender-affirming care. Eplerenone essentially trades versatility for tolerability.
Pediatric Use
Spironolactone is used in children, primarily for heart disease and chronic lung disease in infants. A study of 100 pediatric patients found that it was generally well tolerated at doses around 1.7 to 2 mg per kilogram per day, usually combined with other diuretics like furosemide or thiazides. Potassium levels were slightly higher in children with chronic lung disease compared to those with heart disease, and about a quarter of patients needed potassium supplementation, but no other adverse effects were noted.22PubMed. Clinical experience with spironolactone in pediatrics Pharmacokinetic studies in infants are still working out the details of how the drug and its active metabolites behave in very young children, since dosing cannot simply be scaled down from adult regimens.23PubMed. Pharmacokinetics of oral spironolactone in infants up to 2 years of age
Topical Spironolactone
One of the more interesting recent developments is the use of topical spironolactone, particularly for hair loss. The appeal is straightforward: applying the drug directly to the scalp delivers the anti-androgen effect where it is needed while dramatically reducing the systemic exposure that causes side effects like potassium changes, menstrual irregularity, and breast tenderness. A systematic review found that topical spironolactone showed efficacy for hair regrowth with significantly fewer side effects than oral formulations, and because systemic absorption is minimal, it can be used in men as well, avoiding the gynecomastia and sexual side effects that make oral spironolactone impractical for male patients.9PubMed Central. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review Results were better when topical spironolactone was combined with minoxidil. Topical formulations for acne are also under investigation, though the evidence base is less developed than for hair loss.
Origins of a Surprisingly Versatile Drug
Spironolactone’s journey from a focused diuretic to a multi-specialty workhorse was not planned. After aldosterone was discovered in 1953, researchers began testing synthetic steroids for their ability to block its sodium-retaining effects. The 17-spirolactone steroids emerged from this work, and spironolactone entered clinical use in 1957.24PubMed. The story of spironolactones from 1957 to now: from sodium balance to inflammation At the time, dose-dependent sexual side effects were recognized as a limitation for long-term use, and finding a more selective alternative became an immediate goal.25PubMed. The 45-year story of the development of an anti-aldosterone more specific than spironolactone That search eventually produced eplerenone decades later. But in a twist that the original developers likely never anticipated, the very “side effects” that drove the search for a replacement turned out to be therapeutically useful in their own right. The anti-androgen properties that were considered a drawback in cardiology became the main reason dermatologists, endocrinologists, and gender medicine specialists reach for the drug today. Few medications have had their greatest weakness so thoroughly recast as a strength.